VOR
Vor Biopharma Inc
18.30$
-1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Vor Biopharma Inc (VOR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -143 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -2.7 | -9.9 | -36 | -69 | -85 | -100 | -100 | -143 | |
| 0.0 | 0.1 | 0.6 | 1.4 | 2.5 | 3.5 | 3.5 | 2.9 | |
| 0.1 | 0.2 | 1.3 | 4.3 | 11 | 13 | 9.8 | 19 | |
| 1.4 | 0.7 | 2.1 | 4.5 | 11 | – | – | – | |
| 0.1 | 0.1 | 4.3 | -9.2 | -13 | 0.7 | 0.0 | 10 | |
| 0.7 | 0.7 | 4.2 | 3.9 | 8.5 | 1.1 | 0.2 | 0.9 | |
| -0.7 | -0.7 | -4.2 | -92 | -94 | 71 | 97 | -49 | |
| – | – | – | 188 | 4.5 | -1.2 | – | – | |
| 2.5 | – | – | – | – | – | – | – | |
| 2.5 | 18 | 83 | 233 | 117 | 2.9 | 53 | 504 | |
| -0.2 | 7.1 | 42 | 72 | -62 | -26 | 51 | 312 | |
| -2.7 | -11 | -40 | -73 | -94 | -101 | -100 | -144 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.